Switch to:
More From Other Websites
Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve) Dec 19 2014
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs Dec 16 2014
VERTEX PHARMACEUTICALS INC / MA Files SEC form 8-K, Change in Directors or Principal Officers Dec 15 2014
Is This The Future Of Late-Stage Drug Development? Dec 15 2014
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief... Dec 15 2014
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief... Dec 15 2014
Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data Dec 10 2014
Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study Dec 03 2014
Stock Market News for December 03, 2014 Dec 03 2014
RBC's biotech picks: CELG, BMRN & VRTX Dec 02 2014
7 Biotech stocks to buy now Dec 02 2014
Equity markets end lower, though commodity prices staged a huge “squeeze” higher... Dec 01 2014
Vertex Pharmaceuticals' 52-Week High Driven by Kalydeco Dec 01 2014
Celgene, BioMarin and Vertex are RBC's Top Biotech Buys Dec 01 2014
Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval Nov 26 2014
Today's Stocks Driving Success For The Drugs Industry Nov 25 2014
It was another slow, low volume, lackluster trading session Nov 24 2014
Vertex to Present at Deutsche Bank BioFEST on December 2 Nov 20 2014
Vertex to Present at Deutsche Bank BioFEST on December 2 Nov 20 2014
Insider Trading Alert - LNKD, VRTX And RLGY Traded By Insiders Nov 20 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK